These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 35724509)

  • 1. Diet-gut microbiota-epigenetics in metabolic diseases: From mechanisms to therapeutics.
    Li D; Li Y; Yang S; Lu J; Jin X; Wu M
    Biomed Pharmacother; 2022 Sep; 153():113290. PubMed ID: 35724509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of Gut Microbial Metabolites Derived from Diet on Host Energy Homeostasis.
    Nishida A; Ando Y; Kimura I; Miyamoto J
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications.
    Cuevas-Sierra A; Ramos-Lopez O; Riezu-Boj JI; Milagro FI; Martinez JA
    Adv Nutr; 2019 Jan; 10(suppl_1):S17-S30. PubMed ID: 30721960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota and short chain fatty acids partially mediate the beneficial effects of inulin on metabolic disorders in obese ob/ob mice.
    Guo J; Zhang M; Wang H; Li N; Lu Z; Li L; Hui S; Xu H
    J Food Biochem; 2022 May; 46(5):e14063. PubMed ID: 35128673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary metabolites derived from gut microbiota: critical modulators of epigenetic changes in mammals.
    Bhat MI; Kapila R
    Nutr Rev; 2017 May; 75(5):374-389. PubMed ID: 28444216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota and Metabolic Disorders: Advances in Therapeutic Interventions.
    Akash MSH; Fiayyaz F; Rehman K; Sabir S; Rasool MH
    Crit Rev Immunol; 2019; 39(4):223-237. PubMed ID: 32421966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical School Hotline: Immunoepigenetic-Microbiome Axis: Implications for Health Disparities Research in Native Hawaiians and Pacific Islanders.
    Rubas NC; Maunakea A
    Hawaii J Health Soc Welf; 2021 Aug; 80(8):195-198. PubMed ID: 34355196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease.
    Stols-Gonçalves D; Tristão LS; Henneman P; Nieuwdorp M
    Curr Diab Rep; 2019 May; 19(6):31. PubMed ID: 31044315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases.
    Chen B; Sun L; Zhang X
    J Autoimmun; 2017 Sep; 83():31-42. PubMed ID: 28342734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interplay between diet, gut microbes, and host epigenetics in health and disease.
    Shock T; Badang L; Ferguson B; Martinez-Guryn K
    J Nutr Biochem; 2021 Sep; 95():108631. PubMed ID: 33789148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Diet-Gut Microbiota-Epigenetics Crosstalk Relevant to Neonatal Diabetes.
    Alsharairi NA
    Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Potential Role of Gut Microbiota in the Pathogenesis of Type 2 Diabetes Mellitus
    Sharma B; Kumar A; Sharma U; Pal D; Prashar S
    Endocr Metab Immune Disord Drug Targets; 2022; 22(14):1331-1343. PubMed ID: 35362379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the road to colorectal cancer development: crosstalk between the gut microbiota, metabolic reprogramming, and epigenetic modifications.
    Chen A; Jiang Z; Cai L; Tang D
    Carcinogenesis; 2023 Dec; 44(8-9):631-641. PubMed ID: 37586059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?
    Hou H; Chen D; Zhang K; Zhang W; Liu T; Wang S; Dai X; Wang B; Zhong W; Cao H
    Cancer Lett; 2022 Feb; 526():225-235. PubMed ID: 34843863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
    Nagu P; Parashar A; Behl T; Mehta V
    J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
    Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
    Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
    Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiota and Type 1 Diabetes Mellitus: The Effect of Mediterranean Diet.
    Calabrese CM; Valentini A; Calabrese G
    Front Nutr; 2020; 7():612773. PubMed ID: 33521039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation.
    Kasubuchi M; Hasegawa S; Hiramatsu T; Ichimura A; Kimura I
    Nutrients; 2015 Apr; 7(4):2839-49. PubMed ID: 25875123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.